We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SZLSF market cap is 259.46k. The company's latest EPS is USD -0.0924 and P/E is -0.43.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.74M | 2.6M | 4.15M | 5.07M | 3.8M |
| Operating Income | -3.12M | -2.68M | -3.74M | -8.13M | -15.2M |
| Net Income | -3.69M | -3.48M | -6.86M | -7.48M | -11.42M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.45M | 1.97M | 8.51M | 10.65M | 701k |
| Total Liabilities | 6.96M | 6.46M | 9.74M | 7.88M | 8.2M |
| Total Equity | -5.51M | -4.49M | -1.23M | 2.76M | -7.5M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.46M | -4.59M | -3.06M | -8.96M | -3.53M |
| Investing | -7k | -33k | -72k | -21k | N/A |
| Financing | 3.53M | 4.59M | 9.66M | 4.1M | 1.83M |
| Market Cap | 259.46k |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 1.3 |
| Price to Cash Ratio | 400 |
| Price to Book Ratio | -0.66 |
| Dividend Yield | - |
| Shares Outstanding | 123.55M |
| Average Volume (1 week) | 608 |
| Average Volume (1 Month) | 618 |
| 52 Week Change | -92.22% |
| 52 Week High | 0.9999 |
| 52 Week Low | 0.0015 |
| Spread (Intraday) | 0.7 (99.7%) |
| Company Name | Stagezero Life Sciences Ltd (PK) |
| Address |
unit 30 richmond hill, ontario L4B 2N3 |
| Website | https://www.stagezerolifesciences.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
